Chemotherapy Drug Shortages Raise Concerns

Doctors across the country are facing a critical shortage of vital generic chemotherapy drugs. This shortage raises fears that rationing may become necessary.

The Food and Drug Administration attributes the shortages to several factors. These include manufacturing challenges, shipping delays, and some companies ceasing production. The affected medications have been standard treatments for several types of cancer for years. They are known for their effectiveness, especially when more targeted treatment options are unavailable. This includes treatments for breast, lung, and head and neck cancers.

Ifosfamide, a drug used to treat sarcomas, lymphomas, and testicular cancers, is among those in short supply. Medical professionals are now meeting to decide patient priorities for this drug.

“There are some individuals who won’t be able to receive this drug, even if it is the best option for them, which puts pharmacists, doctors, patients and families in a horrific situation,” said Dr. Andrew Shuman, a head and neck cancer surgeon and professor at the University of Michigan.

In Michigan, where Dr. Shuman practices, decisions are being made to allocate limited doses. Doctors tend to prioritize younger patients who are more likely to benefit and potentially make a full recovery.